We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Dengue Vaccine Enters Phase 3 Trial

News   Jan 15, 2016

 
Dengue Vaccine Enters Phase 3 Trial
 
 
Advertisement
 

RELATED ARTICLES

MS Drug Blocks HIV Infection and Transmission in Human Immune Cells

News

Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis, may be used to block HIV infection and reduce the latent reservoir.

READ MORE

The Microbiome’s Role in Attacking Cancerous Tumors

News

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

READ MORE

Study Links Sex Biases in Drug Dosage Trials to the Overmedication of Women

News

Women are more likely than men to suffer adverse effects of medications because drug dosages have historically been based on clinical trials conducted on men, suggests new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE